For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...
The U.S. Food and Drug Administration (FDA) has issued new draft guidance modernizing statistical methodologies used in ...
Many natural compounds that act on the human body provide active ingredients for medicines or clues for developing them, and ...
Hemostemix receives US FDA support for its basket protocol approach: Calgary, Alberta Tuesday, January 20, 2026, 18:00 Hrs [IST] Hemostemix Inc., the leading autologous stem cell ...
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
Indias first AI-integrated blood biomarker test with PET and MRI imaging shows promises with early Alzheimers detection, ...
Explore the innovative generative AI method transforming drug discovery and material science at unprecedented speeds.
For companies developing interchangeable biosimilars, the FDA guidance opens the door to more tailored, risk-based programs that may reduce reliance on costly comparative efficacy studies (CES). For ...
A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...
Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major ...
Explore the potential of bacteriophages as a breakthrough therapy against bacterial infections amidst rising antibiotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results